Global Market Insights add New Global Intravenous Infusion Pump Market report provides in-depth information about market overview, top vendors, Key market highlights, product types, market drivers, challenges, trends, industry landscape, size and forecast, five forces analysis, Key leading countries/Region.
The Intravenous Infusion Pump Market, segmented by manufacturers, regions, type, and application, is anticipated to reach USD 9.7 billion by 2032. This growth is driven by advancements in infusion technology, increasing demand for precision in drug delivery, and the rising prevalence of chronic diseases requiring intravenous treatments. Key players in the market are focusing on innovation and expanding their product portfolios to meet the growing needs of healthcare providers globally.
The Intravenous Infusion Pump Market, segmented by manufacturers, regions, type, and application, is anticipated to reach USD 9.7 billion by 2032. This growth is driven by advancements in infusion technology, increasing demand for precision in drug delivery, and the rising prevalence of chronic diseases requiring intravenous treatments. Key players in the market are focusing on innovation and expanding their product portfolios to meet the growing needs of healthcare providers globally.
Global Intravenous Infusion Pumps Market by The Business Research Company is segmented as Volumetric, Syringe, Enteral, Ambulatory, IV Disposables, Others
The major competitors covered in the intravenous infusion pump market report are B. Braun Melsungen AG, Baxter International, Medtronic, Fresenius Kabi, Smiths Medical Inc. Read More @ http://bit.ly/34nyIvD
Major Players in the Intravenous Infusion Pump Market are B. Braun Melsungen AG, Baxter International, Medtronic, Fresenius Kabi, Smiths Medical Inc., Becton Dickinson and Company Read More @ https://bit.ly/3l5kQwQ
A recent report published by The Business Research Company on Intravenous Infusion Pumps Market provides in-depth analysis of segments and sub-segments in the global as well as regional. https://bit.ly/3wCyfSL
The global intravenous infusion pumps market is expected to decline from $2.26 billion in 2020 to $2.11 billion in 2021 at a compound annual growth rate (CAGR) of -6.8%.
Patient-controlled analgesic (PCA) pumps represent a crucial component in pain management, allowing patients to administer their own pain relief medication at their discretion within prescribed limits. This method provides autonomy, minimizes delays in pain relief, and aligns with individualized patient care. According to Persistence Market Research's projections, the global PCA pumps market is anticipated to grow steadily, with an estimated CAGR of 7.1%, increasing from a valuation of US$ 360 Million in 2023 to US$ 712 Million by 2033.
Major players in Implantable Infusion Pumps Market Report are Medtronic, Boston Scientific Corporation, Nevro Corporation, Cyberonics, Baxter, B. Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical,. Read More @ https://bit.ly/3aWM2sR
TBRC release its latest prominent report on Ambulatory IV Infusion Pumps Market, in which provide in depth review on global market data, characteristics and regional analysis. https://bit.ly/31rrIwE
Crucial information on R&D status and technology sources of key market players of Global Intravenous Infusion Pump industry is offered in the report. Furthermore, the study offers a detailed analysis of key market growth drivers and restraints along with impact analysis of the same.
Among the Devices Type segments, the Magnetic Pump System with Shielding sub-segment is the largest and is expected to reach a value share of about US$ 93 Mn in 2017. The Tubing and Disposables product type segment is expected to be the second largest product type in the MRI-Compatible IV Infusion Pump Systems Market, increasing at a value CAGR of 7.1% over the forecast period. The Devices Type segment is slated to register a CAGR of 11.6% in terms of revenue during the 10 year period 2017 – 2027.
The global Infusion Therapy Devices Market size is projected to reach a CAGR of 7.3% from 2022-2028. Infusion therapy has become a popular pain relieve treatment method, especially for diseases where oral medication is least effective. In this technique, the drug is usually administered intravenously or subcutaneously. Due to the advancement in various technologies, patients are switching from conventional treatments to specialized infusion therapy treatments as the results are more effective.
The intravenous equipment market is projected to reach USD 27.2 billion by 2032, driven by the increasing prevalence of chronic diseases and the rising demand for advanced healthcare solutions. Growth factors include the widespread adoption of intravenous therapy in hospitals and healthcare settings for administering fluids, medications, and nutrients directly into the bloodstream. Technological advancements in equipment design and functionality are improving patient safety and treatment efficiency.
The home infusion therapy market is expected to grow from US$ 21,765.95 million in 2022 to US$ 35,696.05 million by 2028; it is estimated to record a CAGR of 8.6% from 2022 to 2028 Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biologicals to an individual at home. The components needed to perform home infusion include the drug (antivirals, immune globulin), equipment (a pump), and supplies (tubing and catheters).
According to the latest research report by IMARC Group, The United States home infusion therapy market size reached US$ 19.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 39.7 Billion by 2032, exhibiting a growth rate (CAGR) of 7.90% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-home-infusion-therapy-market
The Global Home Infusion Therapy Services Market witnessed a rapid growth in the historic period from 2016 to 2019 and is anticipated to witness significant growth during the forecast period.
According to the latest research report by IMARC Group, The Saudi Arabia home infusion therapy market size is projected to exhibit a growth rate (CAGR) of XX% during 2024-2032. More Info:- https://www.imarcgroup.com/saudi-arabia-home-infusion-therapy-market
The global home infusion therapy market size in 2021 was estimated at USD 31 billion. It is expected to reach USD 62 billion by 2030, with a CAGR of 8% during the forecast period (2022–2030).
According to the latest research report by IMARC Group, The United States home infusion therapy market size is projected to exhibit a growth rate (CAGR) of XX% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-home-infusion-therapy-market
Growing development of new vaccines and use of advanced technology to design new products are another driver for the market. However, lenient government regulations for approving Intravenous (IV) insulin infusion pumps and risks associated with using needles are the major restraints of this market.
Intravenous Access Devices Market report categorizes global market by Product Type (IV Catheters, IV Infusion Pumps, IV Needles), Catheters (Midline Peripheral Catheters, Peripherally Inserted Central Catheters, Centrally Inserted Central Catheters), End User (Hospitals and clinics, Ambulatory surgery centers), and Geography - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025
According to a new market report published by Persistence Market Research “Global Market Study on Home Infusion Therapy Devices – Needleless Connectors to Witness Highest Growth by 2020”, the global home infusion therapy devices market was valued at US$ 15,905.1 Mn in 2014 and is expected to grow at a CAGR of 9% from 2014 to 2020, to reach US$ 26,747.8 Mn by 2020.
The intravenous (IV) equipment refers to the equipment is utilized to deliver medicine, transfusing blood, rectification of electrolyte imbalances, and maintain blood pressure, among infusing other fluids to the body of the patients. This method is known to be one of the fastest method of providing liquid and solutions to the body.
According to #TechSci Research report, Syringe Pump Market stood at USD20757.85 million in 2021 and expected to grow at CAGR of 6.62% by 2027 on account of factors like as increasing prevalence of chronic diseases. Gain More Insight: https://bit.ly/3r1S1X1 Get Sample Report: https://bit.ly/350awDb Press Release: https://bit.ly/33ObzFs Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/
It is also used in the treatment of diabetes, cystic fibrosis, dehydration, and acute infections. Home infusion therapy reduces time spent by patients in hospitals, nursing homes, and clinics. The therapy is used to administer drugs, antibiotics, nutrients, and other fluids into the veins on a daily, weekly, or monthly basis, depending on the patient’s condition. Home infusion therapy is an effective and safe alternative against conventional hospitalization for the treatment of diseases.
U.S. Home Infusion Therapy Market 2018-2024: This research reviews the overall U.S. home infusion therapy industry, which according to a report, is growing at more than 10% CAGR during 2018 and 2024 to hit the $13.5bn revenue mark.
Intravenous (IV) Therapy and Vein Access market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Intravenous (IV) Therapy and Vein Access market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Intravenous (IV) Therapy and Vein Access market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Intravenous (IV) Therapy and Vein Access market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Home infusion therapy facilitates intravenous at-home administration of medicines into the patient’s body through needle and catheter. The therapy is prescribed by physicians and administered by trained healthcare professionals. It is used when oral medication is not effective for the treatment of diseases such as cancer and gastrointestinal diseases.
The AntiDiabetic Market is segmented based on Product, Administration Route, Patient Age-group and into Insulin segment and Drug segment based on product. Based on Product, the market is subdivided into Insulin Products and Drugs while based on Route of Administration, it is divided into Syringe/Pen, Insulin Pump, Intravenous Infusion and Oral.
The United States Advanced Infusion Systems Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists.
The South Korea Drug Delivery Devices Market report provides value, in millions of US dollars and volume (in units) within market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices... To know more, Click on the link below https://www.kenresearch.com/healthcare/medical-devices/south-korea-drug-delivery-devices/135990-91.html
The injectable drug delivery devices market consists of sales of injectable drug delivery devices and related products such as conventional syringes, needle-free injectors, auto injectors and pen injectors by entities (organizations, sole traders, and partnerships). The market includes the sales of the injectable devices that have been extensively utilized for various routes of drug administration, such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular and others to treat medical conditions ranging from cancer, diabetes to autoimmune disorders.
According to the latest research report by IMARC Group, The global large volume parenteral (LVP) market size reached US$ 9.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032. More Info:- https://www.imarcgroup.com/large-volume-parenteral-market
The global hypodermic needles market is growing at a CAGR of 4.60%, and is expected to reach $xx billion during the forecast period 2023-2032. Get a Free Sample.
A recent report published by Precision Business Insights on IV Equipment Market provides in-depth analysis of segments and sub-segments in the global as well as regional. https://bit.ly/3jrCNW7
According to the latest report by Renub Research, titled "Diabetes Drug Market Global & Forecast By Disease, Oral Therapy, Injection, Insulin, Regions, Company" Diabetes drugs are used to treat pre-diabetes and diabetes mellitus type 2 by controlling the blood glucose level of the body. There are different classes of medicine for the treatment of this diabetes, which are given to patients through oral, intravenous, and subcutaneous routes. According to Renub Research analysis, Global Diabetes Drug Market is forecasted to be US$ 78.10 Billion by 2026. This growth is due to the rising number of diabetes patients worldwide, increasing per capita income. Another reason is with the use of machines; people are following a sedentary lifestyle, which leads to obesity, a decline of physical activity, and consumption of unhealthy meals. Besides, growth in the ageing population is also one of the other reason.
According to Renub Research analysis Global Diabetes Drug Market will be US$ 78.10 Billion by 2026. Forecast for By Disease, Oral Therapy (2020 - 2026)
The recent research, IV Equipment market enables stakeholders, field marketing executives and business owners get one step ahead by giving them a better understanding of their immediate competitors for the forecast period, 2019 to 2030.
The recent research, IV Equipment market enables stakeholders, field marketing executives and business owners get one step ahead by giving them a better understanding of their immediate competitors for the forecast period, 2019 to 2030.
JK MEDIRISE is a healthcare startups company in the international medical devices market. JK MEDIRISE is decade old believing in the statement to deliver the premier quality and international standard Medical device products for the healthcare and medical sector. # Products: * DENTAL IMPLANTS * TRANSFUSION / INFUSION * INTERVENTIONAL CARDIOLOGY * UROLOGY * GASTROENTEROLOGY * ANAESTHESIA * SURGERY * SURGICAL DRESSINGS * SURGICAL DISPOSABLE PRODUCT * MISCELLANEOUS JK MEDIRISE would like to invite you to consider possible business collaborations. Please visit our company website for more information. I am looking forward to hearing from you. With all respect and best regards, Mr. Ketan MUNJANI JK Medirise